Recognizing the importance of a continued commitment to ending pediatric HIV/AIDS worldwide.

HRES 1613 is a non-binding resolution recognizing the U.S. House of Representatives' support for continued U.S. leadership in ending pediatric HIV/AIDS globally. It highlights that 57% of children with HIV were on treatment in 2023 (compared to 77% of adults) and calls for scaling up prevention of mother-to-child transmission and expanding pediatric HIV treatment access. The resolution specifically encourages the PEPFAR program to develop a dedicated pediatric HIV strategy aligned with global goals. As a formal expression of congressional support, it does not create new law but reaffirms the U.S. commitment to reducing new pediatric HIV infections.